Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Gauthier J, Hirayama AV, Purushe J, Hay KA, Lymp J, Li DH, Yeung CCS, Sheih A, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Shadman M, Riddell SR, Maloney DG, Turtle CJ.
Gauthier J, et al. Among authors: lymp j.
Blood. 2020 May 7;135(19):1650-1660. doi: 10.1182/blood.2019002936.
Blood. 2020.
PMID: 32076701
Free PMC article.